Literature DB >> 33568772

Transfusion prevention using erythropoietin, parenteral sucrose iron, and fewer phlebotomies in infants born at ≤30 weeks gestation at a high altitude center: a 10-year experience.

Angela B Hoyos1,2, Pablo Vasquez-Hoyos3,4,5.   

Abstract

INTRODUCTION: Red blood cell transfusions in infants born at ≤30 weeks gestation are frequent. Erythropoietin therapy reduces transfusions. An increase in hematocrit is an adaptive response at high altitudes but a guaranteed source of iron is necessary for adequate erythropoiesis.
METHODS: A retrospective cohort study was done to compare red blood cell transfusion practices of the 2019 EpicLatino (EPIC) Latin America network database with a single unit at 2650 m above sea level (LOCAL). The data from LOCAL for three time periods were compared over 10 years based on changes in erythropoietin dose and fewer phlebotomies. The number of cases that received transfusions and the total number of transfusions required were compared. Adjustments were made for known risk factors using a multivariate regression analysis.
RESULTS: Two hundred and twenty-one cases in LOCAL and 382 cases from EPIC were included. Overall basic demographic characteristics were similar. In EPIC a significantly higher rate of infection (28% vs. 15%) and outborn (10% vs. 1%) was found, but less necrotizing enterocolitis (9% vs. 15%) and use of prenatal steroids (62% vs. 93%) than LOCAL (p < 0.05). EPIC patients received more transfusions (2.6 ± 3 vs. 0.6 ± 1 times) than LOCAL (p < 0.001) and received them significantly more frequently (61% vs. 25%). Within the LOCAL time periods, no statistically significant differences were found other than the need for transfusions (1st 32%, 2nd 28%, 3rd 9%, p = 0.005) and the average number of transfusions (1st 0.8 ± 1.6, 2nd 0.7 ± 1.3, 3rd 0.1 ± 0.3, p = 0.004). These differences remained significant after multivariate regression analysis and adjusting for risk variables.
CONCLUSION: The combination of erythropoietin, parenteral sucrose iron, fewer phlebotomies during the first 72 h, and delayed umbilical cord clamping seem to reduce red blood cell transfusion needs. This can be extremely important in high altitude units where higher hematocrit is desirable but may also be valuable at sea level.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33568772     DOI: 10.1038/s41372-021-00945-7

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   3.225


  45 in total

1.  Early red cell transfusion favourably alters cerebral oxygen extraction in very preterm newborns.

Authors:  C C Andersen; S M Karayil; N A Hodyl; M J Stark
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2015-04-15       Impact factor: 5.747

Review 2.  Heights and haematology: the story of haemoglobin at altitude.

Authors:  Jeremy S Windsor; George W Rodway
Journal:  Postgrad Med J       Date:  2007-03       Impact factor: 2.401

Review 3.  Early erythropoiesis-stimulating agents in preterm or low birth weight infants.

Authors:  Arne Ohlsson; Sanjay M Aher
Journal:  Cochrane Database Syst Rev       Date:  2017-11-16

4.  Cerebral oxygenation in preterm infants receiving transfusion.

Authors:  Deepak Jain; Carmen D'Ugard; Eduardo Bancalari; Nelson Claure
Journal:  Pediatr Res       Date:  2018-12-26       Impact factor: 3.756

Review 5.  Updates in Neonatal Hematology: Causes, Risk Factors, and Management of Anemia and Thrombocytopenia.

Authors:  Isabelle M C Ree; Enrico Lopriore
Journal:  Hematol Oncol Clin North Am       Date:  2019-03-23       Impact factor: 3.722

Review 6.  Red Blood Cell Transfusion in Preterm Infants: Current Evidence and Controversies.

Authors:  Claire Howarth; Jayanta Banerjee; Narendra Aladangady
Journal:  Neonatology       Date:  2018-03-16       Impact factor: 4.035

7.  Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates: Post Hoc Analysis of a Randomized Clinical Trial.

Authors:  Sandra E Juul; Phuong T Vu; Bryan A Comstock; Rajan Wadhawan; Dennis E Mayock; Sherry E Courtney; Tonya Robinson; Kaashif A Ahmad; Ellen Bendel-Stenzel; Mariana Baserga; Edmund F LaGamma; L Corbin Downey; Michael O'Shea; Raghavendra Rao; Nancy Fahim; Andrea Lampland; Ivan D Frantz; Janine Khan; Michael Weiss; Maureen M Gilmore; Robin Ohls; Nishant Srinivasan; Jorge E Perez; Victor McKay; Patrick J Heagerty
Journal:  JAMA Pediatr       Date:  2020-10-01       Impact factor: 16.193

8.  Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.

Authors:  Sanjay M Aher; Arne Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2019-02-15

9.  Transfusion support in preterm neonates <1500 g and/or <32 weeks in a tertiary care center: A descriptive study.

Authors:  R A Shanmugha Priya; R Krishnamoorthy; Vinod Kumar Panicker; Binu Ninan
Journal:  Asian J Transfus Sci       Date:  2018 Jan-Jun

10.  Early erythropoiesis-stimulating agents in preterm or low birth weight infants.

Authors:  Arne Ohlsson; Sanjay M Aher
Journal:  Cochrane Database Syst Rev       Date:  2020-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.